Plasma Levels of Tumor Necrosis Factor in the Adult Respiratory Distress Syndrome

Authors:
  • MMMichèle Markert
    Michèle Markert
  • FFFrançois Feihl
    François Feihl
  • MSMarie-Denise Schaller
    Marie-Denise Schaller
  • MTMarie-Catherine Tagan
    Marie-Catherine Tagan
  • CPClaude Perret
    Claude Perret

Abstract
The purpose of the study was to evaluate the role of tumor necrosis factor alpha (TNFα) in the pathogenesis of acute lung injury in critically ill patients. An immunoradiometric assay with an upper normal limit of 9 pg/ml was used to measure plasma TNFα levels (pl-TNFα) In 34 patients with adult respiratory distress syndrome (ARDS) and in 16 patients in whom, despite the presence of risk factors, ARDS did not develop. Pl-TNFα was elevated in 76% of the patients with ARDS (71 ± 104 pg/ml) and In 48% of the at-risk patients (47 ± 73 pg/ml); the difference between the two groups was not statistically significant. In 13 patients studied serially from the onset (Day 0) to the fifth day of ARDS, the peak pl-TNFα occurred later than Day 0 in seven subjects. Although the highest pl-TNFα levels were found In septic patients, moderately elevated values were also observed in 56% of nonseptic subjects. We conclude that plasma TNFα level is not a marker of ARDS but rather of shock and sepsis. These results do not exclude a pathogenic role of TNFα In acute lung Injury since this cytoklne could be produced and exert its effects within the lungs. The large incidence of abnormally high plasma TNFα levels raises important questions on the role of this toxic cytokine in other disorders occurring in critically ill patients.